Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.